Hal Lieberman

Senior VP, Finance and Administration

Professional Overview
Hal Lieberman is a seasoned finance and administration executive with extensive experience driving strategic initiatives and operational excellence within the pharmaceutical industry. As the Senior Vice President of Finance and Administration at Afecta Pharmaceuticals, he oversees the company's financial management, budgeting, and administrative functions, contributing to the organization's continued growth and profitability.

Experience Summary

Current Role
In his current role as Senior VP, Finance and Administration at Afecta Pharmaceuticals, Hal is responsible for managing the company's financial operations, including financial planning, reporting, and compliance. He plays a key role in optimizing the organization's cost structure, ensuring efficient resource allocation, and supporting the execution of strategic business objectives. Hal's leadership has been instrumental in driving financial discipline and improving the overall financial performance of Afecta Pharmaceuticals.

Career Progression
Hal Lieberman brings a wealth of experience in the pharmaceutical industry, having held various finance and administration roles throughout his career. Prior to joining Afecta Pharmaceuticals, he served as the Vice President of Finance at Meridian Bioscience, where he was instrumental in implementing robust financial controls, streamlining operational processes, and contributing to the company's successful expansion initiatives. Hal's ability to translate complex financial information into actionable insights has consistently made him a valuable asset to the organizations he has served.

Academic Background
Hal Lieberman holds a Bachelor of Science in Accounting from the University of California, Los Angeles (UCLA), where he graduated cum laude. He is a Certified Public Accountant (CPA) and has further enhanced his expertise through executive education programs focused on strategic financial management and leadership development.

Areas of Expertise

• Financial planning and analysis

• Financial reporting and compliance

• Budget management and cost optimization

• Financial risk management

• Mergers and acquisitions integration

• Operational efficiency improvement

• Cross-functional collaboration and team leadership

Professional Impact
During his tenure at Afecta Pharmaceuticals, Hal has played a pivotal role in strengthening the company's financial position and supporting its growth initiatives. Notable achievements include:

• Implemented a robust financial planning and forecasting framework, enabling the organization to make data-driven strategic decisions

• Spearheaded the successful integration of a major acquisition, ensuring a seamless transition and optimizing cost synergies

• Streamlined financial processes and controls, resulting in enhanced operational efficiency and improved reporting accuracy

• Actively participated in the company's expansion into new international markets, providing critical financial guidance and support

Conclusion
With his extensive expertise in finance and administration, coupled with his deep understanding of the pharmaceutical industry, Hal Lieberman is a valuable asset to Afecta Pharmaceuticals. His commitment to driving financial discipline, operational excellence, and strategic growth has consistently contributed to the organization's success. Hal's proven track record and collaborative leadership style position him as a trusted advisor and key contributor to Afecta Pharmaceuticals' continued expansion and long-term profitability.